Bangkok, 28th November 2022 – French President Emmanuel Macron took the opportunity of his attendance to the Thailand-hosted Asia Pacific Economic Cooperation (APEC) Leaders’ Meeting to also meet with the French community residing in Thailand.
During the French community reception organised at Bangkok on Thursday 17 November 2022 President Macron presented France’s strategy for Indo-Pacific region and the importance to strengthen bilateral French-Thai relations. President Macron suggested to take immediate action on economic, academic and scientific priorities and others as highlighted in the Roadmap for Thai – French Relations 2022 – 2024 signed earlier this year in February.
President Macron also announced 2023 will be marked as the Thai – French Year of Innovation with a particular intent to nurture innovation in the fields of science, research, industrial manufacturing, and technological innovation.
Mr Pham attending the French community reception briefly discussed with President Macron about BioNet’s plan to participate to the re-industrialization in France with the creation of a biocluster in Toulouse with partners from the region Occitanie. The biocluster will focus on biotherapies and next generation vaccines using nucleic acid technology platforms, currently not yet available in France.
To facilitate the implementation of the collaborative cooperation in the biocluster creation, BioNet signed a memorandum of understanding with its partners the University Paul Sabatier and the Public Health Institution Centre Hospitalier in Toulouse on Nov 17th, 2022. The biocluster aims at democratising access to those technologies and building a competitive local eco-system.
BioNet will share its expertise in biocluster in Thailand and Australia to the project in France. BioNet has been working with Australia since 2015 and has partnered with biotech companies, life sciences organisations, universities, and hospitals in Australia, leading to the development of 5 genetically designed vaccines.
About BioNet
BioNet is a French-Thai vaccine organization with fully-integrated activities from research to supply chain. We have offices in Europe, Asia, Australia and North America with a manufacturing base in Asia. BioNet is the world’s only manufacturer of recombinant pertussis-only aPgen vaccine (Pertagen®) and a recombinant TdaPgen vaccine (Boostagen®), containing a Genetically inactivated Pertussis Toxin (PTgen). BioNet has also established technology platforms to produce DNA and mRNA vaccines with 10 projects in preclinical and clinical studies. BioNet is advancing global research in collaboration with eminent advisors and organizations (The Pasteur Institute, The Bill and Melinda Gates Foundation, PATH, CEPI and IVI). BioNet has developed bio-clusters fostering vaccine self-reliance around the world and for 20 years, BioNet has driven a unique manufacturers alliance deploying 10 billion doses of polio vaccines worldwide.
www.bionet-asia.com and www.bionet.one
For further information, please contact:
BioNet Europe, Lyon, France : info@bionet.one
BioNet Asia, Bangkok, Thaïlande : info@bionet-asia.com
